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1. Introduction    
The access and use of information technology is increasing in all parts of society and in 
particular in the health care sector in developed and developing countries (Bates & 
Gawanda, 2003; Lucas, 2008). The integration of health information technology into health 
care institutions governs the agenda in most countries presently (Lucas, 2008; Gustafsson et 
al. 2003). The US has recently enacted a $ 19 billion program to promote the use and 
adoption of health information technology (Blumenthal, 2009) and information systems 
including electronic health records (EHR). This program is seen as an essential component 
to improve the health of every American. Challenges discussed span over the whole area of 
installing electronic health records, supporting and updating the systems, assistance with 
the interoperability, training the personal, and implementation of the systems as well as 
medical education (Blumenthal, 2009). Information technology, in particular computerized 
decision support systems, is also seen in the recent report by the Institute of Medicine in the 
US as a key way to address the identified great risk of medication errors in American health 
care institutions (Aspen, 2006).  
A recent European report published by the Swedish government analyses health care in 6 
European member states. The report describes the impact of health technology on several 
political goals such as increasing the availability of health care, continuity, empowerment of 
patients, patient safety and quality of care. It states that in the 6 European member states 
studied, 100 000 yearly inpatient adverse drug events (ADE´s) could be avoided through 
usage of computerised physician order entry systems (CPOEs) with clinical decision 
support (CDS), which would correspond to a yearly saving of 300 million € (Gartner, 2009). 
This report combined with other studies and reviews (Sjöborg et al, 2007; Kelly et al., 2006) 
underlines the complexity of integration and implementation, including local conditions, the 
involvement of stakeholders and adoption and measurements of changes, all of which have 
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to be tackled for a beneficial usage of the technology. The Gartner report envisages that 
increasing costs within the health care sector will accelerate the efforts to develop new 
technologies as well as lead to a beneficial usage of existing systems. 
Computerised physician order entry systems (CPOEs) are one step towards increased safety 
in patient safety. They allow physicians and other health care staff to prescribe patient 
medication directly by using a computer, replacing hand-written orders, and thereby 
eliminating possible interpretation and transcription faults. Transcription and/or 
interpretation errors have been shown to cause 11% of all medication errors resulting in 
adverse drug events in hospitals (Krahenbuhl-Melcher et al., 2007). An additional step to 
improving patient safety and efficacy in the prescribing process is the integration of clinical 
decision support systems (CDS systems) within the CPOEs. This allows physicians to 
retrieve up-to-date medical knowledge of the optimal/recommended management of the 
diseases and drugs, thereby improving patient care through enhancing compliance with 
recent guidelines and recommendations. CDS systems deliver their information through 
knowledge bases (e.g. drug-drug or drug-food interactions, drugs & pregnancy, drugs & 
lactation, drug dosage according to kidney function and genotype and in risk groups), 
which are integrated through software algorithms, that will generate alerts, warnings and 
recommendations during drug  prescribing. For optimisation of the effect of CDS systems, 
they should be integrated into EHRs´ resulting in patient specific recommendations and 
alerts using patient characteristics available in the EHRs. 
Numerous studies have demonstrated positive effects of CDS systems in various settings 
including hospital or ambulatory care, intensive care units and in pediatric care 
(Ammenwerth et al. 2008, Eslami et al. 2008, Wolfstadt et al. 2008, van Rosse et al. 2009). 
Areas of improvement identified include costs, safety, adherence, alerts, user satisfaction 
and time. Reduction of medication errors have been demonstrated with the introduction of 
CDS systems as well as reduction of ADE´s. However, further studies are needed which 
focus directly on patient outcomes rather than the surrogate outcome such as “practitioners’ 
performance” to further accelerate their introduction (Garg et al., 2006). Many studies 
pinpoint improvements of the knowledge bases or CDS systems including optimization of 
the content (Luna et al. 2007), introduction of classification systems to knowledge bases 
(Böttiger et al., 2009), and tiering alerts  through introduction of severity levels (Paterno et 
al., 2009). Their introduction is likely to further improve CDS systems. 
Evidence is growing though that CDS systems might not only lead to improved quality in 
health care but they can themselves create unintended errors jeopardizing patient safety 
(Ash et al., 2004). Introduction of CDS systems might cause diminished medical judgement, 
letting the computer overrule physicians´ own professional knowledge. Additional work 
tasks might create disturbances in the already burdened physicians work flow resulting in 
inefficiencies of the systems. Also the complexity of the systems increases the potential in 
design flaws thereby actually introducing new errors rather than preventing them (Bates et 
al. 2001). Therefore, the implementation and use of any CDS system should be linked to the 
establishment of a medical management, maintenance and quality assurance system, which 
leads to discovering, analysing and foreseeing possible errors.  
Being responsible for paying the drug bill Stockholm County Council, the largest health care 
provider in Sweden, implemented a health care strategy in 1997 including the development 
of an IT architecture (Sjöborg et al., 2007). The aim was to provide numerous services to the 
prescribers to ensure safe and effective drug prescribing. Additional initiatives where 
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started, like the formation of drug expert groups providing a Wise Drug List, which 
contains a list of about 240 first line drugs for common diseases incorporating therapeutic 
ladders or guidelines. Recommendations from 23 expert groups and 5 local drug and 
therapeutic committees are used to produce and refine the guidance. On the IT site 
Stockholm County Council in collaboration with Karolinska Institutet and other academic 
partners has designed, developed and implemented a prescribing tool (Eliasson et al., 2006) 
and the content for medical knowledge bases for drug-drug interactions, Sfinx (Swedish 
Finnish Interaction X-Referencing), drugs & pregnancy, and drugs & breast feeding (Nörby 
et al., 2006, Böttiger et al., 2009). The knowledge bases are integrated into clinical decision 
support tools (Janus toolbar described below) or are accessible through the web 
(www.janusinfo.se). This strategy has been combined with a range of initiatives to promote 
rational use of drugs as described by Godman et al., (2009). The different knowledge bases 
and their life cycle from development to evaluation are used as examples for our own 
experiences in the following parts. 
The review is based on more than 10 years experiences from joint efforts to develop, 
implement and evaluate user friendly and effective decision support systems for drug 
prescribing in Stockholm. It summarizes state-of-the art knowledge on development, 
integration, maintenance, implementation and evaluation of knowledge bases and CDS 
systems used for rational drug prescribing. Consequently, we see this review as a first step 
in the process of creating robust future models and international standards for the retrieval 
of medical and pharmacological knowledge, its conversion and organisation into knowledge 
bases, as well as their integration into CDS systems, their management and evaluation of 
user satisfaction and treatment outcome. 
2. Development of knowledge databases 
Why are knowledge bases needed and what advantages do they offer compared to other 
sources like e.g. the official product SPC (summary of products characteristics) issued as 
part of the registration of a drug product? One advantage with knowledge bases is the 
standardisation of information for all drugs containing the same substance. For instance the 
content of individual SPCs or physician desk references may vary considerably between 
drugs containing the same substance and with identical drug formulations produced by 
different pharmaceutical companies. This can cause confusion for the prescribing physician. 
For example information about drug-drug interactions can be found in the SPC for drug A 
from provider 1 but is missing in the SPC for the same product from provider 2. 
Alternatively, the drug-drug interaction between drug A and B can be found in the SPC text 
for drug A but not for drug B (Bergk et al., 2005). Another example for inconsistencies is the 
classification for drug and pregnancy alerts for pharmaceutical products. One provider may 
state, that the drug should be avoided during pregnancy, but another drug company may 
state, that the drug can be used without any problems. Other examples are variations in 
dosing information (maximum recommended therapeutic dose) between SPCs´ from 
different providers or in information published by the US Food and Drug Administration 
(Seidling et al., 2007). Consequently, knowledge bases should help by providing more 
consistent information about the substances and drugs related to that substance. 
The starting point for development of any knowledge base is the analysis of the perceived 
needs of the potential users in the health care system (Revere et al., 2007). Likewise it is 
important to assess the potential of a new knowledge base to improve efficacy and safety in 
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drug prescribing (Gustafsson et al., 2003; Schiff & Rucker, 1998). We believe the formation of 
user groups should be mandatory to explore the functional and content needs for a 
knowledge base and decision support system before other activities are undertaken 
(Eliasson et al., 2006). Consequently, a multidisciplinary group of clinical experts within the 
medical field the knowledge base should be aimed for (e.g. nephrologists for a database 
about drug dosage in patients with reduced kidney function) together with drug experts 
(e.g. clinical pharmacologists specialised on drug dosage, drug-drug interactions or drugs & 
lactation depending on the knowledge base),  future users, experts within existing drug 
registries and software developers, should be convened to discuss the potential and 
obstacles for the knowledge base (Ash et al., 2004). Our own experience is that there often is 
a mismatch between users’ expectations and the clinical and medical research basis or the 
availability of certain parameters or features within existing registries. For example, the 
clinical specialists will focus on one specific recommendation for the most common 
indications for both drugs for a certain drug-drug interaction. However, this 
recommendation might not fit all patient cases for which this pertinent drug-drug 
interaction alert will be shown, leading sometimes to suboptimal recommendations. 
Another example is that the recommendation to achieve a certain therapeutic drug 
concentration interval can only be given, if there is scientific evidence. In addition, even 
though the potential user of a knowledge base (the general practitioner or any other 
physician) and the drug expert have the same basic medical education, they do not “talk the 
same language” and medical and clinical expertise differs, with clinical experts having more 
knowledge about patient treatment while drug experts possess more information about the 
properties of the drugs used. Medical advice given by the drug expert might not suit the 
practical needs of the physician and on the other hand the specialist physicians´ needs may 
not be fulfilled due to missing medical evidence. 
It is also very important to clarify when CDS systems or knowledge bases can help and 
when they can’t. For example, during the development of the drug-drug interaction 
database Sfinx one of the future users mentioned, that he now finally can detect all the drug 
interactions for herbal drugs his patients always take. But since this physician never enters 
herbal drugs to the patient’s drug list, because he is not prescribing them, he will never get a 
warning for these drugs. 
Prior to the development of the content of a knowledge database the multidisciplinary 
group needs to define its structure. For example developing the drug-drug interaction 
database (DDI db), Sfinx, physicians wished not only to receive warnings on certain drug 
interactions, but also recommendations on how to avoid and handle this interaction 
(Böttiger et al., 2009). The recommendation part is extremely important, since physicians do 
not only want warnings on avoiding certain drug combinations, but would like a 
recommendation how to handle the situation. In a survey among prescribers and 
pharmacists in the US both groups demanded that drug-drug interaction alerts should be 
accompanied by management options of the DDI (Ko et al., 2007). In a recent Australian 
study (Sweidan et al., 2009) recommendations for handling of drug-drug interactions were 
seen as a quality measure for the DDI databases. However, comparing 9 drug interaction 
systems used in primary care only 1 out of 9 systems provided useful management advices. 
A number of studies have demonstrated, that physicians need timely, easy to digest and up-
to-date information, which is filtered, summarized, and synthesized from reliable sources by 
clinical respected experts (Revere et al., 2007; Grol & Grimshaw, 2003; Schiff & Rucker, 
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1998). The expert group needs to define the relevant sources to be used for the knowledge 
base, which might consist of recent research publications, legal documents, information 
from pharmaceutical companies, textbooks, and other databases. It is critical for the integrity 
of the knowledge base to use scientifically rigorous methods for evaluation of scientific data 
by applying critical drug evaluation principles (Godman et al., 2009). Search strategies have 
to be developed and documented in standard operation procedure protocols (SOP´s) to 
assure reproducibility of the search results (Böttiger et al., 2009). This is critical in all cases 
but especially if different people are executing the same task or if expert groups are located 
in different places and can not communicate with each other on a daily basis.  
Figure 1 describes the process from filling a knowledge base with data to providing it to the 
end user. Literature searched will be evaluated by different experts regarding their clinical 
relevance and their level of documentation according to standardised rules. It will then be 
synthesized into short text messages, according to a predefined structure (Böttiger et al., 
2009).  Different content providers have to use the same tool for data entrance. It is advisable 
 
 
Fig. 1. The design and process of building and maintaining a knowledge base to be 
integrated into CDS systems for drug prescribing at point of care or accessible through the 
web. User feed back triggers new literature searches and improves the quality of the 
knowledge base. This figure outlines the data management process for the drug-drug 
interaction database Sfinx (Böttiger et al., 2009). 
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to define in advance certain standard terms for the text messages to avoid heterogenicity in 
the text content. It is easier for the end user to recognise standard phrases for certain 
conditions or recommendations. 
Data are entered into the knowledge base and connected to various other registries or 
databases to assure optimal usage in the CDS system used by the prescribers. We have 
experienced, that access to experts is always the bottleneck in the production of knowledge 
bases, which agrees with the experiences by Kuperman et al. (2006). Consequently, data 
entrance into the knowledge base has to be simplified to save valuable expert time. For 
example through an easy text sharing function the experts should be able to reuse the same 
texts in different documents (e.g. interactions), which follow the same interaction 
mechanisms and rules, as a result reducing both the time for entering data and the size of 
the database. We have developed a terminology model for substances so that substances 
within a class such as different salts of the same substance belong to the same mother 
substance, if they react in the same way (Böttiger et al., 2009). The grouping of substances 
and text sharing function results in an effective and easy way to use the tool which 
simplifies data entrance and database updates. 
Knowledge bases need to be connected to certain registries through software algorithms for 
their optimal use (see Fig. 1). Because texts in knowledge bases usually are written on a 
substance basis they need to be linked to specific drugs which contain the substance. This 
linkage can be done using substance registries, which contain substance names and drugs 
connected to the substance. Key fields for the linkage can be: 
- ATC (Anatomical, therapeutic, chemical classification) codes 
- CAS (Chemical Abstract Service) numbers 
- other nationally available unique identifiers (Böttiger et al. 2009). 
All systems have advantages and disadvantages. The ATC code system is valuable since it 
takes indications of drugs into account.  This can be used to link or exclude drugs containing 
the same substance, but with different formulations or used in different strengths. A 
disadvantage of the ATC code system is the handling of combinational drugs, where the 
content of the drug most often is not specifically defined by the code. CAS numbers identify 
each substance in a unique way, which allows correct linkage. Problems within the system 
are its complexity. For example a substance which appears to be the same might have a 
different CAS number due to its varying content of crystal water, which is not obvious from 
the description of the drug. Another disadvantage is the limited use of CAS numbers in 
national registries. National identifiers might be the optimal way for linkage of knowledge 
bases to drug registries. However, substance based national identifiers do not take drug 
dosages into account. A substance can have a different interaction profile due to variations 
in dose (for example: high-dose versus low-dose acetylsalicylic acid). Consequently linkage 
just by a substance identifier would lead to wrong interactions alerts. Another disadvantage 
of national identifiers is, that the national identifier can’t be used across nations, a problem 
we faced for the Sfinx database distributed in Sweden and Finland. Whatever registry or 
system is used for linkage it is of great importance to ensure correct update and 
maintenance of the registries as described in the next chapter. 
If drug formulations are relevant for the triggered alert, these should be taken into account. 
Even here it is important to simplify matters for the knowledge expert and create drug 
formulation groups (e.g. all sorts of tablets, capsules or oral solutions should be grouped 
under the term “peroral”). The Swedish drug registry contains about 650 different drug 
formulations, which we have grouped into 5 different groups in the “drug formulation 
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classification file” (Fig.1) to support data entrance. International standard terms are needed 
to reduce the work load for a single country and to facilitate the integration with other drug 
registries from other nations. To our knowledge there is no European or worldwide registry 
with standardised drug formulations available, which could facilitate integration of 
knowledge bases across countries. 
Finally database updates have to follow the same procedures and rules as defined for the 
starting phase. Ideally, they should include incorporating the handling of end user 
comments and feedback for further improvement and refinement (Böttiger et al., 2009). Each 
specific update should be tested, documented and saved in order to be able to trace back 
incorrect alerts reported by the end users. 
3. Combined quality assurance for knowledge bases and linked registries 
Quality assurance of the knowledge bases and their linkage to other registries is an essential 
task often forgotten as it is time consuming, labour-intensive and requires significant effort 
and expertise. Quality assurance does not only refer to the medical content in question but 
stretches over the whole procedure from literature searches, the evaluation process to the 
linkage of the knowledge base to local or national registries and thereby requires 
experienced multidisciplinary staff. 
Literature about quality assurance processes within clinical databases is limited. Quality 
assurance papers in medicine mainly deal with securing the quality for a certain medical 
treatment or procedure, but are not extended to databases and CDS systems. It is amazing 
that still today EHRs or CDS systems do not need to be certified by health or medical 
agencies. However, due to the increasing awareness of the possibility that information 
technology implemented into health care can actually increase the error rate  even with risk 
for higher mortality rate (Han et al. 2005), changes are on their way both in the US 
(Blumenthal, 2009) and Europe (EU directive; 2007/47/EC;2007). Certification should cover 
not only the technical part of these systems, but should include even the medical content of 
knowledge bases integrated into CDS systems and implementation of the systems. 
Quality assurance is mostly self evolving during the development phase of any database 
system including the handling of external registries for linkage purposes. Baorto et al. (2009) 
describe the experiences they made with the maintenance of a large medical ontology at one 
of the larger hospitals in New York. They state that the methods described even though 
developed specifically for their system can be used for carrying out similar tasks at other 
institutions. Many of the problems and procedures mentioned mirror exactly the situation 
with the development of our knowledge base systems. In our mind resources and expertise 
for quality assurance processes are needed for integration and maintenance of high quality 
knowledge bases. Standards need to be developed in this area. 
Combining different registries or other knowledge sources has to be performed using “key 
fields” like ATC codes, specific identifiers, or CAS-numbers. We were surprised though 
when comparing different registries that the information in key fields could vary. For 
example a drug could be assigned to a specific ATC code in one registry and this could vary 
from the code in another registry. This could be due to simple typing mistakes, system 
requirements of the registry owner, delays in the update process or other possibilities. We, 
like Baorto and colleagues (2009), used the “diff approach” for detection of theses variations, 
where you compare two registries regarding the information in predetermined fields using 
the information in key fields to link the registries. For example we assume that a drug with a 
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specific registration number has to have the same name, ATC code and drug formulation in 
all registries. Another approach to detect variations is to compare an older version of the 
same file with the newer one discovering changes for already existing fields, and new posts 
entered to the file. Logs are produced during the comparison process, which mainly have to 
be evaluated manually. Possible mistakes are corrected in the registries and reported to the 
source owners for correction in the original source.  
Over the years we have discovered many mistakes at the point of acquisition of the data 
including missing information in essential fields (they were either completely empty or 
omitted), changes in the meaning of existing codes, existence of wrong characters in the 
master file or creation of redundant terms. The “diff approach” is also used for updating the 
knowledge base system, e.g. to identify new substances on the market, which will then be 
added and grouped into the mother child terminology, to discover new drug formulations, 
which have to be included into the drug formulation file, or to seek for new drugs on the 
market, which have to be linked to certain knowledge bases. The linkage has to be correct 
both technically and content wise else care will subsequently be compromised. For example, 
you can’t link some new ear drops, containing a substance you already have in your 
knowledge base, to that base, if the text document is irrelevant for this new drug. 
Auditing terminology and data structure of the registries linked to the knowledge base is 
mainly performed manually through reviewing log files created during the import process, 
which flag for changes and differences. These processes are labour-intensive and time 
consuming. Some of these audit processes though can be automated or at least semi-
automated to save time and resources. For example, if you want to add a new substance 
child to the registry the hierarchy principle within your database requires the existence of 
the mother substance to be consistent with previously existing structures. Other examples 
are rules you create for maintenance purposes, like no two medications with the same 
registry number are allowed with different names.  
As Baorto et al. (2009) stated quality assurance and maintenance of the knowledge base and 
its linked registries is a “mission critical” task that cannot tolerant errors. If we do not add 
one specific, new ATC code to a document the new drug assigned to that code will fail to be 
considered by the alerting system. It must be recognised though that all quality assurance 
processes rely at least partly on human surveillance so they are inevitably prone for 
mistakes. One can never be sure, that the knowledge base is completely correct. However, 
we can increase our confidence in the database through implementation of audits, rules and 
log files. This will help to create a system, which is detecting and minimising a large 
percentage of potential errors. 
Any errors that occur through the usage of the knowledge base have to be handled by the 
medical management and maintenance system in a systematic way to enhance the utility of 
the database. This is described below. 
4. Medical management and maintenance system for knowledge bases and 
CDS systems 
The development and implementation of several knowledge bases, CDS systems and other 
IT applications within health care required the introduction of a surveillance system for 
possible errors introduced by its applications as an essential pre-requisite for the 
management of these systems. Our department has implemented a maintenance system, 
which allowed smooth handling of all procedures linked to its databases and depending 
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registries e.g. regular update processes of the medical content, improvements or changes in 
the graphical interface and IT structure or adapting to new external registries. At the same 
time the EU Directive, 2007/47/EC, amending among others the Directive 93/42/EEC 
(http://Eur-Lex.europa.eu) concerning medical devices is under implementation in 
Sweden, and supports the process by raising the requirements for software and information 
systems used for clinical decisions regarding individual patients. 
Important parts for the function of knowledge bases and CDS systems are management, 
maintenance and quality assurance of these applications after their implementation, 
together with handling of possible errors introduced by the systems, which could be of 
either technical or medical nature. Clinical, medical, and pharmaceutical competences, as 
well as competences in various IT-areas and in implementation are needed. Additionally, 
complete technical documentation of the knowledge base and the CDS system as well as 
guidelines (standard operation procedures = SOPs´) for producing their content and its 
distribution have to be part of the management plan to secure standardized procedures and 
avoid occurrence of mistakes. 
Documented incidents include all kinds of subjects i.e. requests for further information, e-
services, training, as well as reporting of major or minor errors. Minor or major errors 
include discussions of diverse opinions about recommendations or conclusions in the 
knowledge base, wishes for changes in classification levels or inclusion criteria. Technically 
it could be problems in the applications, or its documentation, or errors regarding the 
technical integration including design and functionality of user interfaces. All incidents are 
documented in the management system. Within the management and maintenance system 
the experiences we have made through real incidents and errors enable us to perform risk 
analysis on a regular basis. This helps us to foresee and judge possible incidents, which 
might occur through changes in the content, the graphical interface or the technical solution 
of our systems. 
4.1 Management of errors using root cause analysis 
The medical management of incidents or errors involves the processes of discovering the 
incidents, collecting documentation, performing event analysis and, if required, reporting of 
the error as a medical event - named Lex Maria - to the authorities in Sweden (Shemeikka et 
al., 2008). Root cause analysis (RCA) is a technique originally developed in psychology and 
systems engineering to identify “the basic and casual factors that underlie variation in 
performance”. We use RCA to investigate errors after they are discovered. It involves critical 
incident reporting followed by self-managed investigation of the event involving all staff in 
charge. It should answer three basic questions: 
- what happened? 
- why did it happen? 
- what could be done to prevent it from happening again? 
The investigation team consists of colleagues from the department and includes everybody 
involved in the processes related to the incident. 
In the US root cause analysis for investigations of medical errors became mandatory in 1997 
for hospitals accredited by the US Joint Commission on Health Care Safety. Models used for 
RCA were further developed and adopted for by health care systems in other countries like 
Australia (Iedema et al., 2005). Though RCA used in the US and other countries only 
included medical procedures and not handling of errors introduced by decision support 
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systems, we have applied the technique for handling of our knowledge bases and decision 
support tools as well as the e-prescribing system. We have relied on experiences by team 
members from using the method in pharmaceutical companies to handle reports on adverse 
drug reactions, and from the health care system reporting events when harm or risk of harm 
for the patient has occurred during medical treatment.  
Once an error of the CDS system is reported an initial rapid assessment is performed of the 
potential immediate and long term clinical consequences. If there is any risk for the safety of 
the patient or other patients due to the error, a decision is taken to shut down the e-services 
or keep it going whilst performing immediate changes. In these cases a report is sent to the 
national authorities in charge of monitoring and guarding patient safety during clinical care. 
The error is documented in detail often by requesting additional information from the 
reporter. The next step is to perform RCA to investigate the reason for the error (Iedema  et 
al., 2005) and to suggests changes in for example the system, content, procedures or 
technical and user interfaces. 
Incidents can be due to medical (e.g. wrong medical recommendation), pharmacological 
(e.g. wrong pharmacological mechanism thought to be cause for a DDI) or pharmaceutical 
(e.g. drugs with wrong formulations can be linked to a text) errors in the content of the 
knowledge base, or due to an unclear text, leading to misinterpretation. Errors in drug 
linkage can result in wrong alerts for a certain drug or missing alerts. The reason for the 
error could also be of technical nature. RCA may lead to organisational changes like 
education of the personal or policy changes, though they have a lower probability of 
reducing risk (Wu et al. 2008). It may also lead to changes of the content or processes for 
producing the knowledge bases or CDS systems or in redesign of the product or processes 
linked to knowledge base or CDS system, which are actions with a high probability of 
reducing risk (Wu et al., 2008). Procedural changes may lead to updates in the 
documentation or SOPs´ for the knowledge bases. Any changes in the device will be 
followed by extensive tests of the modified application before reintegration into the work 
environment. If the incident does not depend on one’s own systems but on the EHR the CDS 
system is implemented in, the health record system owner has to solve the problem and 
document and proof changes. These changes are performed in close contact with vendors 
and producers of electronic health record systems. 
Other incidents like inappropriate handling of the CDS system by the user may lead to a 
modification of the system and if necessary, user training must be performed. An example 
of a RCA is shown in figure 2 and 3. It describes an incident, where an ATC code was 
connected to a medical document by mistake. Drug name and ATC code was incorrectly 
send to the authors of the knowledge base. This led to the addition of the code to the 
document by the authors and a wrong linkage of drugs to the document. Processes for 
quality assurance of linkage of drugs to documents failed due to various reasons (technical 
equipment; frequent change of personal involved in the process). Consequently, users 
searching on the web for one of these drugs in one of our knowledge bases ended up in a 
document which had nothing to do with the drug searched for. Even if RCA has some 
benefits, including increased awareness of faulty processes and fixes to specific problems, 
more emphasis should be placed on drawing lessons across investigations rather than to 
approach each RCA independently. Most important, follow-up for implementation and 
outcome of each RCA and its actions should become a standard element of the process (Wu 
et al. 2008)   
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A new pharmaceutical 
product, Rapydan, containing 
tertracaine and lidocaine to be added 
to the knowledge base on safety of 
drugs during pregnancy by updating 
an existing document.
The new product containing 
tetracaine and lidocaine is added 
to a list in a word document with 
its ATC code for combination. No 
information is added that other 
drugs containing different 
substances use the same ATC 
code.
The list is sent to the clinical experts 
of the knowledge base.
The existing text for tetracaine in 
XML formate is updated by the 
expert due to the new product. 
The text is tagged incorrectly with 
the ATC code stated in the word 
document list.
An automated control is 
performed regarding changes of 
ATC code in the XML file. It is 
noted that a new ATC code is 
added to the tetracaine 
document.
There is no routine to 
state in the ATC column 
of the list that several 
drugs containing different 
substances share the 
same ATC code.
No control before 
updating the text, by the 
clinical experts, if the 
ATC code is shared with 
other drugs.
To introduce a new 
routine where possible 
shared ATC codes are 
stated in the list of new 
products.
To clarify and inform 
about the routine that 
exists where a control 
always should be made if 
an ATC code is shared 
by several drugs before 
the code is added to the 
list.
A new routine to always 
add the information from 
the national medical 
products registry to the 
comment field in the list 
in cases when ATC 
codes are shared.
Introduction of an 
operating procedure on 
how changes of text in 
the XML file should be 
done.
Actions:
Causation:
Incident chain:
Why? Why?
Procedures and routines: 
Poor procedures.
 Procedures and routines. 
Poor procedures.
 
Fig. 2. RCA part 1: On the top of each RCA the incidents following each other and leading to 
the mistake are stated. Next line gives the reasoning for each incident. These are followed by 
the causes, grouping the reasons into categories. Each reason is followed by one or several 
actions suggested. 
4.2 Analyses of risks 
Risk analyses are also included into the management and maintenance system. Using the 
experiences made with existing systems we apply this knowledge to other parts of the 
knowledge base and the CDS system to foresee possible risks. On a regular base we perform 
preventive risk analysis to identify and classify different kinds of risks. The method has 
been adapted and is now used even during development of new CDS systems or knowledge 
bases in our setting in Stockholm. It improves our possibilities to evaluate the costs, risks, 
and improvements made with the implementation of new knowledge bases or decision 
support tools. For example when the graphical interface of the decision support system is 
changed risk analysis can be performed on possible effects for end user performance. 
5. Providing medical knowledge bases at point of care 
The knowledge base can either be provided: 
- as a website solution 
- integrated into EHR systems 
- used in learning tools. 
The integration into EHR systems facilitate the exchange of patient-specific data with the 
knowledge base, thereby creating patient-specific alerts or reminders during the process of 
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The update of the tetracaine 
document with the new ATC 
code that is shared with other 
drugs is controlled, accepted 
and added to the knowledge 
base.
Pharmaceutical products that don´t 
contain tetracaine but share the same 
ATC code are seen on the web wrongly 
when reading about tetracaine.
It is not observed that 
through the ATC code 
also other drugs are 
connected to the text
Unclear description 
manual of the routine 
how the ATC code 
control should be 
performed.
Short time to introduce 
new personal to the 
control process.
The technical application 
performing the control 
has technical deficiencies 
and its easy to loose 
control of how far in the 
process the test has
come.
Change in the routine 
description for how the 
control step of the text 
has to be performed 
added details how to 
control the ATC code.
Improve and increase the 
time for  education of new 
staff members in the 
routines of the control 
step. 
A new technical 
application for the control 
step of the texts .
Clarify and inform how 
routines should be in 
order to avoid the system 
tool to crash during the 
control step.
Why?
Why?
Procedures and routines: 
Poor routines
Management system: 
Education lacking
Technical equipments 
and tools: Deficient tool.
The persons performing 
the control were changed 
repetedly and didn´t 
initially know the routines.
Management: Poor 
planning.
Policy change: personal
performing the control 
step shouldn’t be 
replaced that frequently .
Incident chain:
Causation:
Actions:
 
Fig. 3. RCA part 2: the second part of the incident chain explains, how the document with 
the wrong ATC code was added to the database without proper controls of the document 
and the effect it had on the linkage of drugs to the document. Actions suggested include 
changes in routines and policies, education and even changes in the technical tools used. 
drug prescribing. The integration into an EHR system should be performed in collaboration 
between the providers of the knowledge base and the owners of the EHR systems. Contracts 
should specify the implementation of the database and how it is to be used and presented to 
the end user. The organizations implementing CDS systems must have detailed knowledge 
of the structure of the knowledge base and the architecture of the CDS system so that it is 
clear, how the systems interact (Kuperman et al.2006). Intensive testing of its integration 
following predefined protocols should be required to avoid unintended errors or mistakes 
due to lack of experiences and knowledge of the product. One must be sure that the 
knowledge base is behaving as intended (Kuperman et al. 2006). 
The knowledge bases for drug-drug interactions, Sfinx, drugs & pregnancy and drugs & 
lactation produced by Stockholm County Council are provided free of charge through the 
county website on www.janusinfo.se. The website is aimed at health care personal. 
Physicians or nurses can search various knowledge bases by typing in the patient’s 
medication and receive advice, whether specific drugs can be used during pregnancy or 
breast feeding or should be avoided (Norby et al., 2006). Drug-drug interactions can be 
searched for in Sfinx by either substance or drug names.  
However, for optimal use knowledge bases should be implemented into a CDS system 
linked to an EHR, which will send patient specific data such as age, sex, height, weight,  
parameters for kidney function and the current drugs a patient is being prescribed to the 
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knowledge base. Through certain software algorithms an alert or reminder could then be 
triggered or not, providing patient specific warnings for e.g. drug-drug interactions, drugs 
& lactation or drugs & breast feeding. 
The DDI database Sfinx is integrated into the CDS system Janus toolbar, providing patient 
specific automatic alerts during drug prescribing (Sjöborg et al., 2007). In figure 4 we 
describe an example of the decision support system provided through Janus toolbar 
integrated into one EHR system in Stockholm County Council. The patient’s name, sex and 
age can be seen at the top of the screen. The prescribing module within the EHR contains the 
current drug list, consisting of 4 different drugs. Sending those data to the knowledge base 
for DDIs´, pregnancy and breast feeding the alert buttons will be illuminated, if there is any 
information to be retrieved (Eliasson et al., 2006, Sjöborg et al., 2007). It is of great 
importance that the EHR and the knowledge base interact in an optimal and correct way. 
For example in a survey among ambulatory care clinicians in Massachusetts it was 
observed, that the local CDS system often delivered alerts with out-of-date medications, 
which led to scepticism towards the system among users (Weingart et al. 2009).  
 
 
Fig. 4. Implementation of Janus toolbar into an EHR. Patient specific alerts are illuminated 
related to the patient’s age, sex and current list of drugs. Several different knowledge bases 
are the basis of the decision support system. For every new order of medication a new drug 
list will be send to the knowledge base, evaluated and may lead to changes in the alerts. 
To further improve user friendliness, accessibility, and speed of the CDS system the most 
important information of the knowledge base should be short and concise only one click 
away. This principle is implemented into the Janus toolbar with the most important message 
Shortcut to 
website 
DDI alert Drug & 
pregnancy 
alert 
Drug & breast 
feeding alert 
Table of 
side effects
Patient drug list 
Patient name 
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being provided immediately, while for information about possible mechanisms, background 
studies for the statement and references users have to click further (Eliasson et al, 2007, 
Böttiger et al. 2009). We believe this quick access to pertinent information enhances the 
utilisation of the support tool. Even other surveys have shown that important information 
should be easily accessible and speed of use is a critical factor for the successful use of 
medical information systems (Dawes & Sampson, 2003; Bates et al., 2001). 
Figure 5 shows the information provided by the knowledge base for drug-drug interactions, 
- Sfinx. Sfinx was developed by us together with partners from clinical pharmacology in 
Finland and in Sweden (Böttiger et al., 2009). Clicking on the yellow alert button, which is 
illuminated according to the patients’ drug list, short and concise information about the 
medical consequence and recommendations can be seen immediately. Additional more 
educational information is available through clicking on the “read more” button. 
 
 
Fig. 5. Warning texts of the drug-drug interaction database, Sfinx. The yellow colour code is 
used for interactions classified as “C” which means, that the interaction is clinical relevant 
but the drug combination can be handled by for example dose adjustment (Böttiger et al., 
2009). A short consequence text describes, what can be expected medically. This is followed 
by a recommendation part, stating how to handle the interaction. 
The Janus toolbar alert system delivers non-intrusive reminders. This means that the 
illuminated warnings are optional not forcing the physician to take any action and not 
disturbing the workflow for the practitioners. Shah et al. (2006) showed that acceptance of 
drug alerts was improved by minimizing workflow disruptions, designating only high 
severity alerts to be interruptive to clinicians work. Disadvantages with intrusive alerts are 
disruption of physicians’ workflow and increased tendency to ignore, work around or 
override these warnings. In a survey by Krall & Sittig (2001) physicians indicated that 
intrusive or active alerts might be more useful but less easy to use. It was also stated that 
another important factor for increased compliance and effectiveness of a CDS system is the 
interface design in relation to the workflow process. Alerts showing up too early or too late 
in the workflow process might lead to decreased compliance and reliability of the users in 
the system or even worse, lead to errors and harm for the patient (Krall & Sittig, 2001; 
Khajouei & Jaspers, 2008). 
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Studies on the effectiveness of non-intrusive versus intrusive alerts are contradictory. One 
study (Palen et al., 2006) showed no significant difference between control and intervention 
groups in the overall rate of compliance to ordering certain laboratory monitoring values 
when prescribing certain medications. They used non-intrusive alerts in their intervention 
group. Another study (Tamblyn et al., 2008) compared the effectiveness of on-demand 
versus computer triggered decision supports regarding dosing information, drug-drug, 
drug-age, -allergy and -disease interactions. They found that physicians in the computer-
triggered group saw more alerts, and made more changes. However, they also ignored more 
of the alerts shown (87.8%). The on-demand group requested less than 1 % of all alerts 
provided by the CDS, but ignored only 24.4%. There was no difference in the overall result 
of existing prescribing problems after intervention between both groups. 
We believe that CDS systems need to keep a balance between producing too many alerts 
and reminders and delivering the message in a straight-forward manner. Too many alerts 
are likely to be overridden and cause “alert-fatigue”, which leads to underestimation of the 
CDS systems as useful tools in the daily practice (Shah et al. 2006). To avoid too many 
uncritical alerts classification of the content of knowledge bases regarding clinical 
significance is of great importance. Numerous studies have shown that compliance to CDS 
systems and user satisfaction is related to the balance between useful alerting and 
overalerting (Paterno et al. 2009; Shah et al. 2006). Therefore, we have implemented 
classification systems in all our knowledge bases. Classification is performed regarding the 
clinical significance of the content and the level of documentation for the alerts. Colour 
codes are provided additionally to knowledge base specific classifications (letter or number 
codes) thereby supporting the prescriber, to identify the urgency of the information 
retrieved from the knowledge base. The red colour signalises very important messages (e.g. 
for drug- drug interactions it means: avoid combination) (Böttiger et al., 2009). A yellow 
colour code indicates information, which should be retrieved and could influence the 
prescribing (e.g. dose adjustment for a DDI warning). White colour means that information 
of more theoretical value is available but it has no clinical relevance which has to be 
considered during prescribing. 
Isaac and colleagues (2009) recently showed, that physician’s tendency to override alerts 
was less pronounced for the alerts with high-severity / high risk compared to medium or 
low severity alerts.  Tiered alerting for severity for drug-drug interaction information, like in 
Sfinx, is one possibility to increase compliance rates for interaction warnings. That was 
confirmed in a study by Paterno et al (2009), where compliance in the tiered DDI alert group 
was significantly higher than in the non-tiered group (29% vs. 10%). Additionally, the most 
severe alerts were accepted to 100% in the tiered group while only 34% in the non-tiered 
group.  
Commercially available DDI databases tend to put more emphasis on covering the whole 
medical domain rather than differentiating between clinical important and non-important 
messages. So there is a need for increased specificity to reduce extraneous workload and 
reduce “alert-fatigue”. Luna et al. (2007) described the need to “clean” the content of their 
commercially purchased knowledge base according to the clinical significance of drug-drug 
interactions. By creating a classification for DDIs in the system they customized the 
knowledge base for their organisation. 
Spina et al. (2005) investigating the usefulness of different types of alerts in a CDS system in 
a group of primary care physicians stated that more tailored systems are needed, where DDI 
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warnings on topical drugs should be avoided, when not relevant. Therefore drug 
formulations should be taken into account in a DDI knowledge base (Böttiger et al., 2009). 
Also interaction warnings should be suppressed, when drug monitoring is already in place. 
Another option can be to suppress warnings on reorders for patients’ medications as shown 
by Abookire et al. (2000). They found that overriding rates for drug allergy warnings 
increased from 48% to 83% for drugs being reordered for a single patient over a certain time 
period, suggesting that physicians tend to ignore warnings for the patients permanent 
medications, since they have handled and considered these alerts already once before. 
Consequently, tailoring systems focussing more on new ordered medications rather than on 
drug renewals would be another possibility to increase usefulness of CDS systems. 
However, it will not be possible to develop knowledge bases and CDS systems fitting all 
needs. Personal adjustments seem to be necessary since physicians´ needs and their varying 
level of knowledge result in different perceptions of any CDS system. 
6. Implementation of CDS systems 
Healthcare agencies spend significant amounts of money on the development of clinical 
information systems, though often failing with successful implementation. Designing an 
effective approach for increasing end-user acceptance and subsequent use of IT- systems is a 
fundamental challenge. Successful implementation needs comprehensive approaches 
tailored to clinical settings and target groups taking individual, health care team, and 
organizational variations into account.  
Wears & Berg (2005) described how implementation of any new technology into a clinical 
workplace triggers both changes in the workplace and in the use of technology, which itself 
triggers development of the technology (Figure 6). A workplace is described as a field where 
social behaviour meets technology and both influence each other. 
It is also of great importance to consider the different interests in and views on a CDS 
system from users, administrators and vendors. Ash and colleagues (2003) described the 
complex interplay of physicians, administrators and IT- staff when implementing a 
computerized physician order entry (CPOE) system into a hospital setting. They looked at 
three important parts, which are always influenced by an implementation: the technical, 
organizational and personal part. Physicians thought the CPOE as technically cumbersome 
and time-consuming, forcing them to think like computers and click through various 
screens. They also felt that the CPOE was “forced” on them by hospital administration not 
taking into account the work situation which they believed was already overburdened. 
However, on a personal note they felt a need to master the system. The hospital 
administration thought the system technically to be cost-effective and delivering great 
statistics. People in the organisation felt pride in being at the forefront of technology. 
Personally they felt pride in having overcome the clinicians’ resistance. The information 
technology staff perspective on the technical system was the urge and tendency to make the 
system even more useful, train the users and fulfil and develop the system according to the 
users wishes. Organisationally they tried to identify the right staff members for the 
implementation to reach everybody in the hospital. Personally they described enthusiasm 
for the benefits of the system, but at the same time they felt implementation as difficult and 
painful but useful in the long run. This study reflects the difficulties of a successful 
implementation taking into account the various expectations of different “interest groups”. 
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Fig. 6. Influences of technology in a clinical workplace environment. This figure shows that 
any new technology integrated into a clinical workplace will change work practice, which 
then will result in use of the technology different as planned from the beginning. This will 
trigger the development and change of the technical tool implemented (Wears & Berg, 2005)  
Ash and colleagues (2003) derived four categories of principles for a successful 
implementation:  
- computer technology 
- personal principles 
- organizational principles 
- environmental issues. 
These principles reflect the need to consider multiple issues during implementation and 
they highlight the relationship between technology, clinical information, people and 
organizational issues. Callen et al. (2008) described a Contextual Implementation Model 
(CIM), which is based on data from sites, where physicians use an existing CPOE system. 
The model acknowledges the complexity of the clinical environment and the requirements 
of the users. They concluded that implementation should start with a thorough analysis of 
the context where the CDS system will be implemented into. This analysis should include all 
three levels namely organisational, departmental and individual. Work practices have to be 
studied on an individual and department level. Computer literacy and keyboard skills have 
to be investigated among potential users and work requirements between departments have 
to be clarified to take the differences between organizations into account. Requirements of 
Clinical workplace
=
Sociotechnical 
system 
New 
technology 
Work practice
Use of 
technology 
Implementation
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the CDS systems on individual and workplace level have to be investigated and differences 
can be included in the implementation plan so that during implementation one can 
accommodate the different needs. Targeted training programs can eliminate the problem 
with different keyboard skills and computer literacy. Analysis of organizational and team 
cultures will assist with modifying the cultures to increase receptiveness. They concluded 
that using the CIM model for implementation will facilitate the usage and benefit of any 
CDS system. 
In a systematic review (Gruber et al., 2009), it was stated, that no single implementation 
strategy has proved to be completely effective. The authors defined a theoretical model for a 
computerised decision support system including five major steps in the life cycle of any 
CDS system (= Expanded Systems Life Cycle = ESLC): 
- planning 
- analysis 
- design 
- implementation 
-  maintenance 
They identified risk zones for each phase and corresponding risk factors. Their analysis 
revealed that the highest number of failure and success were in the implementation zone 
focusing on preimplementation and “go-live” of the system. They also identified that 
training and education, attention to training, policy, process changes, and training to clinical 
content are key factors influencing the success or failure of a CDS system. 
However, more research is needed to avoid costly errors in implementation. Studies 
focussing on barriers and incentives for changes should be performed focussing on various 
levels (namely the innovation itself, the professional, the patient, the social context, the 
organisational context, and the economic and political context) as suggested (Grol & 
Wensing, 2004). 
7. Evaluation 
Rigorously designed evaluations and research on the effectiveness of decision support 
systems are needed to assess their value in clinical practice and to identify areas for 
improvement in design and implementation. Kirkpatrick described four levels of evaluation 
in which the complexity of the behavioural change increases as evaluation strategies ascend 
to each higher level (Kirkpatrick, 1967). The four levels measure 
- reaction to information 
- learning 
- behaviour 
- results 
Studies assessing effects of CDS systems on patient outcome are urgently needed. They are 
difficult to perform due to the length of time needed for the evaluation, the lack of reliable 
objective measures, and the number of potential confounding factors. 
The selection of methodology to investigate an implementation of decision support systems 
is no different from choosing methods in any other type of research. A variety of study 
designs can be used to evaluate if decision support systems influence prescribing behaviour 
and patient outcomes. These studies include quasi-experimental designs (uncontrolled or 
controlled before-and-after studies and interrupted time series) and randomized controlled 
trials (RCTs) (Grimshaw et al., 2000). The RCT has the highest degree of evidence as non-
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randomized designs might introduce selection bias by including in the intervention group 
doctors or clinics that favour the particular intervention (Grimshaw et al., 2000, Stephenson 
& Imrie, 1998). The control group design considers other factors influencing the prescribing 
pattern such as seasonal variations in disease patterns, the introduction of new drugs and 
changes in treatment policies, the marketing activities of pharmaceutical companies and 
changes in regulatory policies (Grimshaw et al., 2000). However, due to ethical, practical 
and methodological reasons, they are seldom possible to apply when evaluating the impact 
of decision support systems. Therefore, well-designed quasi-experimental studies may be 
the method of choice. 
Alternative research strategies include qualitative research methods to provide a deeper 
understanding of the subjective aspects of the interaction between healthcare professionals, 
patients and the electronic tools. The common feature of qualitative studies is that they do 
not primarily seek to provide quantified answers to research questions. The goal of 
qualitative research is the development of concepts which can help us to understand social 
phenomena in natural rather than experimental settings, giving due emphasis to the 
meanings, experiences, and views of all the participants (Pope & Mays, 1995). Examples of 
qualitative methods include in-depth interviews, focus group discussions, observations and 
various consensus methods. 
Development and evaluation of a complex system, such as a CDS system and implementing 
it into the health care organisation require a multiple research approach i.e. method 
triangulation. The evaluation of the pilot study of the Janus decision support system had 
primarily a qualitative approach with focus on user satisfaction. Semi-structured qualitative 
interviews were performed with all users before, during and after the pilot study. By 
concentrating the evaluation on user satisfaction we gained data both on the technical 
failures as well as the physicians’ attitudes to medical content and usefulness of the system 
and acceptance in clinical work. The evaluation and implementation were carried out by a 
multidisciplinary team within a small scale user clinic in order to be able to easily detect 
technical and practical obstacles (i.e. integration bugs) and even more serious potential 
quality problems of the pharmacological sources (i.e. pregnancy and breast-feeding alerts in 
the Swedish PDR) (Eliasson et al., 2006). Data and support were handled in a rapid way to 
be able to give direct feed-back to the user. Our experiences confirm that evaluations of 
small-scale pilot studies for proof of concept are important tools in the design of an optimal 
intervention that improves health care quality so that resources are used in an optimal way 
as stated by Harvey & Wensing (2003).  
The results of the pilot study even helped us to identify factors, which have major impact on 
usefulness of the CDS system and user satisfaction and led to a two-part theoretical model 
for implementation and evaluation (Eliasson et al, 2006). This model considers both system-
dependent and system-independent factors (Figure 7). The first part includes system-
dependent factors, such as medical content, user friendliness and user support. The second 
system-independent part includes personal attitudes of the prescribers´ towards computer 
use as well as the attitude of the organisation towards implementing a CDS system. 
Stockholm County Council conducts regular evaluations after pilot studies which we see as 
a cornerstone for development of successful electronic tools. The effectiveness of Janus 
toolbar and the frequency of its use, and users’ characteristics are measured by 
questionnaires. Simultaneously, interviews are carried out to explore doctors’ and other 
prescribers’ experiences and perceptions of Janus toolbar. Those evaluations were used to 
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Fig. 7. A two-part theoretical model for evaluation of the CDS system taking system 
dependent (e.g. medical content, usability, support) and system independent factors (e.g. 
personal attitudes, organizational aspects) into account. 
decide about the development of a new knowledge base for drug-drug interactions Sfinx, 
which is described above. The regular follow-ups over years showed results similar to the 
actual literature especially in terms of satisfaction, acceptance and intention to use (Krash, 
2004, Ahearn & Kerr, 2003; Magnus et al., 2002). Physicians generally overrode the 
interaction warnings and expressed irritation on the irrelevant alerts, which often led to 
ignore them. Furthermore, physicians were dissatisfied with the usability, information and 
training of how to use the tool, and complained about technical barriers. Although 
physicians did not seem to use the tool in every day practice they underlined the clinical 
value and needs of it, i.e. being reminded of unknown /known drug-drug interactions and 
getting recommendations about how to avoid them. Prescribers were aware of the fact that 
the decision support system contributes to safer and more effective treatment of the patients. 
They were clear about their needs for the system and had good intentions to use it. 
However, even after thorough analysis of physicians’ needs, we could observe that the 
system was not fully used after its implementation. 
Some contributing factors are changes in expectations and intentions of the users from the 
initial discussion, to later implementation and the actual use at the work place when the 
database is integrated into daily work flow. Another influencing factor is that CDS systems 
integrated into daily practice suddenly offer more complete knowledge about patients’ 
medications for the physicians, demanding new decisions and work tasks that GPs were not 
aware of. Physicians have different views on their responsibilities for diagnosis, drug 
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treatment and follow-up of a patient resulting in different actions and variations of handling 
the information provided. Recently we have highlighted that there is a need for common 
and understandable rules on prescribing physicians´ responsibility in handling the total 
patients’ drug lists. These lists are made available to all prescribers through a newly 
implemented IT-tool (Rahmner et al., 2009). We can conclude that work flow, working 
environment and processes influence physicians’ behaviour to a greater extent than expected.  
Consequently, we still do not know how to design optimal CDS systems which affect and 
influence physicians’ behaviour in drug prescribing. The challenge for the future 
development and implementation of a CDS system into health care is to find a method to 
achieve and maintain expected changes in prescribing behaviour.  
8. Summary 
Knowledge bases provide the contents for any clinical decision support system. In this 
review we characterize the life cycle of a knowledge database to be used in drug 
prescribing. The various phases and the important issues in each phase are summarized in 
table 1. Knowledge bases need to fulfil and be tailored to the needs of the users. The focus of 
the content should be on practical use in a clinical environment, rather than covering the 
whole scientific area of a medical speciality. Standards are needed to be able to use 
knowledge bases across different electronic health care systems and countries, since clinical 
expertise is often the bottle neck for any development. 
Integration of knowledge bases into CDS systems implemented into electronic health record 
system optimises their effectiveness by delivering patient specific reminders and alerts. The 
linkage between knowledge bases and CDS systems needs to be quality assured. Knowledge 
bases and CDS systems need to be surveyed through a management and administration 
system handling incidents and errors due to system or its content. Though many studies 
have shown the positive influence of CDS systems on physicians’ performance, there is still 
lack of understanding, when CDS systems improve performance. Outcome studies on 
patient care are lacking. Implementation of CDS systems has to be accompanied by staff 
education and training to assure acceptance and effectiveness even throughout the 
maintenance phase. More studies are needed with focus on actual improvement of patient 
safety and care instead of investigating physicians change in prescribing drugs. 
With that in mind knowledge bases and CDS systems will prove to be helpful tools in the 
daily decision making process of any busy clinician when instituting and evaluating the 
drug therapy of a patient. 
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Life cycle phase of a 
knowledge base 
Important issues for each life cycle phase 
Development 
Thorough analysis of physicians needs 
 
Standardisation of data structure, implementation of 
classification system, optimal linkage to drug registries 
Quality assurance 
Control of quality in key fields for linkage 
 
Introduction of semi-automated and manual processes for 
data auditing 
Medical management & 
maintenance 
Well documented and standardized procedures for  
knowledge base maintenance 
 
Root Cause Analysis for analysis of mistakes and follow ups 
of the planned actions 
Providing knowledge 
bases at point of care 
Integration into electronic health records for patient specific 
alerts 
 
Tailored systems with fast data access to avoid overalerting 
and increase acceptance 
Implementation 
Consider interests of users, organizations and vendors within 
the implementation plan 
 
Education, personal training, attention to process changes are 
key factors 
Evaluation 
Evaluation of small scale projects as important tools in the 
design of optimal interventions 
 
Regular evaluations necessary to secure optimal use of 
knowledge base or CDS system 
Table 1. Summary of important messages for each step in the life cycle of a knowledge base. 
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